214 related articles for article (PubMed ID: 37089929)
1. Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney.
Li R; Shi C; Wei C; Wang C; Du H; Hong Q; Chen X
Front Pharmacol; 2023; 14():1131635. PubMed ID: 37089929
[No Abstract] [Full Text] [Related]
2. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological potential of Astragali Radix for the treatment of kidney diseases.
Shi Y; Shi X; Zhao M; Ma S; Zhang Y
Phytomedicine; 2024 Jan; 123():155196. PubMed ID: 37952410
[TBL] [Abstract][Full Text] [Related]
4. Biological active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular diseases.
Li M; Han B; Zhao H; Xu C; Xu D; Sieniawska E; Lin X; Kai G
Phytomedicine; 2022 Apr; 98():153918. PubMed ID: 35104756
[TBL] [Abstract][Full Text] [Related]
5. Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine.
Chen Z; Liu L; Gao C; Chen W; Vong CT; Yao P; Yang Y; Li X; Tang X; Wang S; Wang Y
J Ethnopharmacol; 2020 Aug; 258():112895. PubMed ID: 32330511
[TBL] [Abstract][Full Text] [Related]
6. Effects of compound Shenhua tablet on renal tubular Na+-K+-ATPase in rats with acute ischemic reperfusion injury.
Yang Y; Wei RB; Zheng XY; Qiu Q; Cui SY; Yin Z; Shi SZ; Chen XM
Chin J Integr Med; 2014 Mar; 20(3):200-8. PubMed ID: 24464369
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects and Mechanisms of Shenhua Tablet () on Toll-Like Receptors in Rat Model of Renal Ischemia-Reperfusion Injury.
Li QP; Wei RB; Yang X; Zheng XY; Su TY; Huang MJ; Yin Z; Chen XM
Chin J Integr Med; 2019 Jan; 25(1):37-44. PubMed ID: 28466227
[TBL] [Abstract][Full Text] [Related]
9. Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology.
Zhang Z; Fang J; Sun D; Zheng Y; Liu X; Li H; Hu Y; Liu Y; Zhang M; Liu W; Zhang X; Liu X
Evid Based Complement Alternat Med; 2022; 2022():6987677. PubMed ID: 36561604
[TBL] [Abstract][Full Text] [Related]
10. [Exploration of potential efficacy markers of Astragali Radix for invigorating Qi based on systematic traditional Chinese medicine].
Bian YQ; Li J; Peng S; Lyu TY; Zhang YL; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3266-3274. PubMed ID: 32726039
[TBL] [Abstract][Full Text] [Related]
11. Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis.
Geng W; Wei R; Liu S; Tang L; Zhu H; Chen P; Wu J; Zhang X; Zhu F; Yin Z; Chen X
Biol Res; 2016 Mar; 49():17. PubMed ID: 26969153
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV: A promising natural neuroprotective agent for neurological disorders.
Yao M; Zhang L; Wang L
Biomed Pharmacother; 2023 Mar; 159():114229. PubMed ID: 36652731
[TBL] [Abstract][Full Text] [Related]
13. Effects of Physical Properties and Processing Methods on Astragaloside IV and Flavonoids Content in
Chien MY; Yang CM; Chen CH
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056893
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications.
Li L; Zhang Y; Luo Y; Meng X; Pan G; Zhang H; Li Y; Zhang B
Drug Des Devel Ther; 2023; 17():771-790. PubMed ID: 36925998
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV, a saponin from Astragalus membranaceus var. mongholicus, induces expressions of heme recycle proteins via signaling of Nrf2/ARE in cultured macrophages.
Gong G; Yu H; Zheng Y; Qi B; He H; Yin T; Dong TT; Tsim KW
J Ethnopharmacol; 2021 Jan; 265():113389. PubMed ID: 32920134
[TBL] [Abstract][Full Text] [Related]
16. Quality evaluation for Radix Astragali based on fingerprint, indicative components selection and QAMS.
Huang J; Yin L; Dong L; Quan H; Chen R; Hua S; Ma J; Guo D; Fu X
Biomed Chromatogr; 2018 Nov; 32(11):e4343. PubMed ID: 30003570
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer.
Yang B; Yang N; Chen Y; Zhu M; Lian Y; Xiong Z; Wang B; Feng L; Jia X
Front Pharmacol; 2020; 11():580978. PubMed ID: 33628171
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on Astragali Radix and prediction of its quality markers (Q-markers)].
Dai YT; Zhang XY; Wang YX; Fan YS; Yang D; Liu YQ; Xiu MH; He JZ
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(7):1754-1764. PubMed ID: 35534246
[TBL] [Abstract][Full Text] [Related]
19. Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.
Jiang H; Li J; Wang L; Wang S; Nie X; Chen Y; Fu Q; Jiang M; Fu C; He Y
J Ethnopharmacol; 2020 Aug; 258():112913. PubMed ID: 32371143
[TBL] [Abstract][Full Text] [Related]
20. [Simultaneous Determination of Five Astragalosides in Astragali Radix and Jinqi Jiangtang Tablet by HPLC-ELSD].
Ding FF; Deng YR; Zhang XJ; Sun Y; Guo LP
Zhong Yao Cai; 2015 Jan; 38(1):156-9. PubMed ID: 26214884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
